Trials / Completed
CompletedNCT03862794
CMO Letter to Reduce Unnecessary Antibiotic Prescribing and Broad Spectrum Prescribing Winter 2018-9
A Randomized Controlled Trial of Behaviourally Informed Feedback Letters Sent by the Chief Medical Officer on the Amount of Antibiotics and the Percentage of Broad Spectrum Antibiotics Prescribed in Primary Care
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7,000 (actual)
- Sponsor
- Public Health England · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This trial aims to reduce unnecessary prescription of antibiotics and broad spectrum antibiotics by general practitioners (GPs) in England. Unnecessary prescriptions are defined as those that do not improve patient health outcomes. The intervention is to send GPs a letter from the Chief Medical Officer (CMO) that gives feedback on their practice's prescribing levels. Specifically the sample was GPs whose practices whose prescribed more than 1.161 items per STAR-PU or whose practices prescribed more that .965 items per STAR-PU and greater than 10% broad spectrum items. The intervention groups received a letter telling them they are among the highest prescribers of either their total or broad spectrum antibiotics, with a graph showing their prescribing compared to average prescribing ("their peers"). The letter also contained a leaflet to help GPs discuss self-care advice with patients and some advice to use delayed prescriptions. The investigators hypothesize that the antibiotic prescribing rate in will be lower for the treatment group compared to the control group, following the receipt of the letter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | new social norm feedback letter with bar chart | letter with the percentile prescribing the practice is on and a bar chart, comparing prescribing to the national average |
| BEHAVIORAL | standard social norm feedback letter | social norm feedback letter used as standard practice, without specific information about the prescribing percentile |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2019-04-30
- Completion
- 2019-05-30
- First posted
- 2019-03-05
- Last updated
- 2020-03-03
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03862794. Inclusion in this directory is not an endorsement.